CCM
ALXN

Covington Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Covington Capital Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-852
Closed -$157K – 1070
2021
Q2 		$157K Buy
852
+695
+443% +$119K 0.01% 387
2021
Q1 		$24K Buy
157
+7
+5% +$1.08K ﹤0.01% 579
2020
Q4 		$23K Hold
150
– – ﹤0.01% 569
2020
Q3 		$17K Hold
150
– – ﹤0.01% 575
2020
Q2 		$17K Hold
150
– – ﹤0.01% 576
2020
Q1 		$13K Sell
150
-230
-61% -$22.6K ﹤0.01% 584
2019
Q4 		$41K Sell
380
-162
-30% -$17.3K ﹤0.01% 501
2019
Q3 		$53K Hold
542
– – ﹤0.01% 438
2019
Q2 		$71K Buy
542
+53
+11% +$6.83K ﹤0.01% 390
2019
Q1 		$66K Buy
489
+31
+7% +$3.85K ﹤0.01% 387
2018
Q4 		$45K Hold
458
– – ﹤0.01% 439
2018
Q3 		$64K Hold
458
– – ﹤0.01% 398
2018
Q2 		$57K Hold
458
– – ﹤0.01% 412
2018
Q1 		$51K Hold
458
– – ﹤0.01% 427
2017
Q4 		$55K Buy
458
+97
+27% +$11.8K ﹤0.01% 445
2017
Q3 		$51K Buy
+361
New +$49K ﹤0.01% 432

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Covington Capital Management's ALXN Position: Q3 2021 in Review

Covington Capital Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 852 shares — an estimated $157K sold.

Covington Capital Management first reported a position in ALXN in Q3 2017 and held it in 16 quarters. The position peaked at $157K in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Covington Capital Management reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Covington Capital Management sold 852 Alexion Pharmaceuticals shares in Q3 2021, an estimated $157K.
  • Covington Capital Management first reported a position in Alexion Pharmaceuticals in Q3 2017 and held it in 16 quarters.
  • Covington Capital Management's Alexion Pharmaceuticals position peaked at $157K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Covington Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.